- Home
- RCKY vs BDTX Comparison
RCKY vs BDTX Comparison
Compare RCKY & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKY
- BDTX
- Stock Information
- Founded
- RCKY 1932
- BDTX 2014
- Country
- RCKY United States
- BDTX United States
- Employees
- RCKY N/A
- BDTX N/A
- Industry
- RCKY Shoe Manufacturing
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RCKY Consumer Discretionary
- BDTX Health Care
- Exchange
- RCKY Nasdaq
- BDTX Nasdaq
- Market Cap
- RCKY 196.3M
- BDTX 181.4M
- IPO Year
- RCKY 1993
- BDTX 2020
- Fundamental
- Price
- RCKY $30.06
- BDTX $3.19
- Analyst Decision
- RCKY Buy
- BDTX Strong Buy
- Analyst Count
- RCKY 1
- BDTX 6
- Target Price
- RCKY $40.00
- BDTX $12.50
- AVG Volume (30 Days)
- RCKY 55.3K
- BDTX 836.3K
- Earning Date
- RCKY 10-29-2025
- BDTX 11-04-2025
- Dividend Yield
- RCKY 2.12%
- BDTX N/A
- EPS Growth
- RCKY 24.23
- BDTX N/A
- EPS
- RCKY 2.48
- BDTX 0.25
- Revenue
- RCKY $462,328,000.00
- BDTX $70,000,000.00
- Revenue This Year
- RCKY $7.02
- BDTX N/A
- Revenue Next Year
- RCKY $3.96
- BDTX N/A
- P/E Ratio
- RCKY $11.78
- BDTX $12.66
- Revenue Growth
- RCKY N/A
- BDTX N/A
- 52 Week Low
- RCKY $11.93
- BDTX $1.20
- 52 Week High
- RCKY $33.04
- BDTX $6.23
- Technical
- Relative Strength Index (RSI)
- RCKY 59.78
- BDTX 60.46
- Support Level
- RCKY $28.64
- BDTX $3.13
- Resistance Level
- RCKY $29.69
- BDTX $3.43
- Average True Range (ATR)
- RCKY 0.90
- BDTX 0.17
- MACD
- RCKY -0.15
- BDTX 0.02
- Stochastic Oscillator
- RCKY 60.73
- BDTX 68.89
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.